Baseline characteristics of adult patients commencing dialysis in Australia between 2005 and 2022.
| . | Descriptive statistics . | |||
|---|---|---|---|---|
| Characteristics . | Haemodialysis via autologous AVF . | Haemodialysis via CVC . | Peritoneal dialysis . | Overall . |
| Patient-level characteristics | ||||
| Number of patients | 14 298 | 20 620 | 12 494 | 47 412 |
| Age starting dialysis (years, mean ± SD) | 62.7 (14.0) | 60.9 (15.8) | 59.7 (15.2) | 61.1 (15.1) |
| Men (n, %) | 9419 (66) | 12 486 (61) | 7682 (62) | 29 587 (62) |
| Ethnicity (n, %) | ||||
| Caucasians | 10 456 (74) | 14 325 (70) | 8415 (68) | 33 196 (71) |
| Asians | 1090 (8) | 1771 (9) | 2148 (17) | 5009 (11) |
| Indigenousa | 1911 (13) | 3418 (17) | 1066 (9) | 6395 (14) |
| Others | 728 (5) | 942 (5) | 767 (6) | 2437 (5) |
| BMI (mean ± SD) | 29.8 (7.4) | 28.5 (7.8) | 27.3 (5.7) | 28.6 (7.2) |
| BMI categories (n, %) | ||||
| Underweight | 251 (2) | 733 (4) | 342 (3) | 1326 (3) |
| Normal | 3543 (25) | 6507 (32) | 4157 (34) | 14207 (31) |
| Overweight | 4368 (31) | 6093 (30) | 4402 (36) | 14863 (32) |
| Obese | 5895 (42) | 6789 (34) | 3457 (28) | 16141 (35) |
| Dialysis modality (n, %) | ||||
| Peritoneal dialysis | 12 494 (100) | 12 94 (26) | ||
| Haemodialysis | ||||
| Facility haemodialysis | 13 819 (97) | 20 578 (99.8) | 34 397 (73) | |
| Home haemodialysis | 479 (3) | 42 (0.2) | 521 (1) | |
| Smoking status (n, %) | ||||
| Non-smoker | 6690 (48) | 9568 (47) | 6311 (51) | 22 569 (48) |
| Current smoker | 1570 (11) | 2784 (14) | 1323 (11) | 5677 (12) |
| Ex-smoker | 5797 (41) | 7980 (39) | 4728 (38) | 18 505 (40) |
| Comorbidities | ||||
| Chronic lung disease (n, %) | 1705 (12) | 3053 (15) | 1069 (9) | 5827 (12) |
| Coronary artery disease (n, %) | 4637 (33) | 7426 (36) | 3284 (26) | 15 347 (33) |
| Peripheral vascular disease (n, %) | 2310 (16) | 3964 (19) | 1647 (13) | 7921 (17) |
| Cerebrovascular disease (n, %) | 1434 (10) | 2391 (12) | 1099 (9) | 4924 (10) |
| Diabetes mellitus (n, %) | ||||
| Type 1 | 519 (4) | 983 (5) | 711 (6) | 2213 (5) |
| Type 2 | 6817 (48) | 9920 (48) | 4905 (39) | 21 642 (46) |
| Cancer (n, %) | 1743 (12) | 2688 (13) | 1056 (9) | 5487 (12) |
| Late nephrologist referral (n, %) | 799 (6) | 7215 (35) | 1294 (11) | 9308 (20) |
| Cause of kidney failure (n, %) | ||||
| Diabetic nephropathy | 5573 (39) | 8110 (40) | 4280 (34) | 17 963 (38) |
| Glomerular kidney disease | 2584 (18) | 3713 (18) | 2983 (24) | 9280 (20) |
| Hypertension nephrosclerosis | 2048 (14) | 2855 (14) | 1817 (15) | 6720 (14) |
| Familial/genetic kidney disease | 1481 (10) | 687 (3) | 1063 (9) | 3231 (7) |
| Tubulointerstitial disease | 1310 (9) | 1675 (8) | 1121 (9) | 4106 (9) |
| Others | 1214 (9) | 3431 (17) | 1173 (9) | 5818 (12) |
| Geographical location (n, %) | ||||
| Urban | 9371 (66) | 13 421 (66) | 8739 (70) | 31 531 (67) |
| Regional | 3900 (28) | 5411 (27) | 3186 (26) | 12 497 (27) |
| Remote | 909 (6) | 1602 (8) | 499 (4) | 3010 (6) |
| Socio-economic status (n, %) | ||||
| Low | 4258 (30) | 6333 (31) | 3909 (32) | 14 500 (31) |
| Mid | 5444 (38) | 7715 (38) | 4707 (38) | 17 866 (38) |
| High | 4469 (32) | 6379 (31) | 3804 (31) | 14 651 (31) |
| State/territory at dialysis initiation (n, %) | ||||
| New South Wales | 3685 (26) | 6027 (29) | 4591 (37) | 14 303 (30) |
| Queensland | 2933 (21) | 4156 (20) | 2383 (19) | 9472 (20) |
| Victoria | 3770 (26) | 4678 (23) | 2937 (24) | 11 385 (24) |
| Australian Capital Territory | 301 (2) | 518 (3) | 162 (1) | 981 (2) |
| South Australia | 1316 (9) | 1246 (6) | 816 (7) | 3378 (7) |
| Western Australia | 1404 (10) | 2573 (13) | 1216 (10) | 5193 (11) |
| Northern Territory | 605 (4) | 1017 (5) | 159 (1) | 1781 (4) |
| Tasmania | 284 (2) | 405 (2) | 230 (2) | 919 (2) |
| Era (n, %) | ||||
| 2005–10 | 3957 (28) | 6249 (30) | 3318 (27) | 13 524 (29) |
| 2011–16 | 4702 (33) | 6246 (30) | 4244 (34) | 15 192 (32) |
| 2017–22 | 5639 (39) | 8125 (40) | 4932 (40) | 18 696 (39) |
| Pre-emptive transplant (n, %) | 78 (0.5) | 125 (0.6) | 91 (0.7) | 294 (0.6) |
| Centre-level characteristics | ||||
| Number of centres | 101 | 104 | 67 | 106 |
| Transplant centre (n, %) | 17 (17) | 17 (16) | 16 (24) | 18 (17) |
| Centre size (median, IQR) | ||||
| Incidence dialysis patient/year | 57 (31–101) | 62 (38–101) | 78 (45–113) | 64 (38–106) |
| Incidence PD patient/year | 13 (5–27) | 15 (6–27) | 22 (7–39) | 16 (7–30) |
| Incidence HD patient/year | 44 (24–70) | 46 (28–71) | 48 (31–70) | 46 (28–70) |
| . | Descriptive statistics . | |||
|---|---|---|---|---|
| Characteristics . | Haemodialysis via autologous AVF . | Haemodialysis via CVC . | Peritoneal dialysis . | Overall . |
| Patient-level characteristics | ||||
| Number of patients | 14 298 | 20 620 | 12 494 | 47 412 |
| Age starting dialysis (years, mean ± SD) | 62.7 (14.0) | 60.9 (15.8) | 59.7 (15.2) | 61.1 (15.1) |
| Men (n, %) | 9419 (66) | 12 486 (61) | 7682 (62) | 29 587 (62) |
| Ethnicity (n, %) | ||||
| Caucasians | 10 456 (74) | 14 325 (70) | 8415 (68) | 33 196 (71) |
| Asians | 1090 (8) | 1771 (9) | 2148 (17) | 5009 (11) |
| Indigenousa | 1911 (13) | 3418 (17) | 1066 (9) | 6395 (14) |
| Others | 728 (5) | 942 (5) | 767 (6) | 2437 (5) |
| BMI (mean ± SD) | 29.8 (7.4) | 28.5 (7.8) | 27.3 (5.7) | 28.6 (7.2) |
| BMI categories (n, %) | ||||
| Underweight | 251 (2) | 733 (4) | 342 (3) | 1326 (3) |
| Normal | 3543 (25) | 6507 (32) | 4157 (34) | 14207 (31) |
| Overweight | 4368 (31) | 6093 (30) | 4402 (36) | 14863 (32) |
| Obese | 5895 (42) | 6789 (34) | 3457 (28) | 16141 (35) |
| Dialysis modality (n, %) | ||||
| Peritoneal dialysis | 12 494 (100) | 12 94 (26) | ||
| Haemodialysis | ||||
| Facility haemodialysis | 13 819 (97) | 20 578 (99.8) | 34 397 (73) | |
| Home haemodialysis | 479 (3) | 42 (0.2) | 521 (1) | |
| Smoking status (n, %) | ||||
| Non-smoker | 6690 (48) | 9568 (47) | 6311 (51) | 22 569 (48) |
| Current smoker | 1570 (11) | 2784 (14) | 1323 (11) | 5677 (12) |
| Ex-smoker | 5797 (41) | 7980 (39) | 4728 (38) | 18 505 (40) |
| Comorbidities | ||||
| Chronic lung disease (n, %) | 1705 (12) | 3053 (15) | 1069 (9) | 5827 (12) |
| Coronary artery disease (n, %) | 4637 (33) | 7426 (36) | 3284 (26) | 15 347 (33) |
| Peripheral vascular disease (n, %) | 2310 (16) | 3964 (19) | 1647 (13) | 7921 (17) |
| Cerebrovascular disease (n, %) | 1434 (10) | 2391 (12) | 1099 (9) | 4924 (10) |
| Diabetes mellitus (n, %) | ||||
| Type 1 | 519 (4) | 983 (5) | 711 (6) | 2213 (5) |
| Type 2 | 6817 (48) | 9920 (48) | 4905 (39) | 21 642 (46) |
| Cancer (n, %) | 1743 (12) | 2688 (13) | 1056 (9) | 5487 (12) |
| Late nephrologist referral (n, %) | 799 (6) | 7215 (35) | 1294 (11) | 9308 (20) |
| Cause of kidney failure (n, %) | ||||
| Diabetic nephropathy | 5573 (39) | 8110 (40) | 4280 (34) | 17 963 (38) |
| Glomerular kidney disease | 2584 (18) | 3713 (18) | 2983 (24) | 9280 (20) |
| Hypertension nephrosclerosis | 2048 (14) | 2855 (14) | 1817 (15) | 6720 (14) |
| Familial/genetic kidney disease | 1481 (10) | 687 (3) | 1063 (9) | 3231 (7) |
| Tubulointerstitial disease | 1310 (9) | 1675 (8) | 1121 (9) | 4106 (9) |
| Others | 1214 (9) | 3431 (17) | 1173 (9) | 5818 (12) |
| Geographical location (n, %) | ||||
| Urban | 9371 (66) | 13 421 (66) | 8739 (70) | 31 531 (67) |
| Regional | 3900 (28) | 5411 (27) | 3186 (26) | 12 497 (27) |
| Remote | 909 (6) | 1602 (8) | 499 (4) | 3010 (6) |
| Socio-economic status (n, %) | ||||
| Low | 4258 (30) | 6333 (31) | 3909 (32) | 14 500 (31) |
| Mid | 5444 (38) | 7715 (38) | 4707 (38) | 17 866 (38) |
| High | 4469 (32) | 6379 (31) | 3804 (31) | 14 651 (31) |
| State/territory at dialysis initiation (n, %) | ||||
| New South Wales | 3685 (26) | 6027 (29) | 4591 (37) | 14 303 (30) |
| Queensland | 2933 (21) | 4156 (20) | 2383 (19) | 9472 (20) |
| Victoria | 3770 (26) | 4678 (23) | 2937 (24) | 11 385 (24) |
| Australian Capital Territory | 301 (2) | 518 (3) | 162 (1) | 981 (2) |
| South Australia | 1316 (9) | 1246 (6) | 816 (7) | 3378 (7) |
| Western Australia | 1404 (10) | 2573 (13) | 1216 (10) | 5193 (11) |
| Northern Territory | 605 (4) | 1017 (5) | 159 (1) | 1781 (4) |
| Tasmania | 284 (2) | 405 (2) | 230 (2) | 919 (2) |
| Era (n, %) | ||||
| 2005–10 | 3957 (28) | 6249 (30) | 3318 (27) | 13 524 (29) |
| 2011–16 | 4702 (33) | 6246 (30) | 4244 (34) | 15 192 (32) |
| 2017–22 | 5639 (39) | 8125 (40) | 4932 (40) | 18 696 (39) |
| Pre-emptive transplant (n, %) | 78 (0.5) | 125 (0.6) | 91 (0.7) | 294 (0.6) |
| Centre-level characteristics | ||||
| Number of centres | 101 | 104 | 67 | 106 |
| Transplant centre (n, %) | 17 (17) | 17 (16) | 16 (24) | 18 (17) |
| Centre size (median, IQR) | ||||
| Incidence dialysis patient/year | 57 (31–101) | 62 (38–101) | 78 (45–113) | 64 (38–106) |
| Incidence PD patient/year | 13 (5–27) | 15 (6–27) | 22 (7–39) | 16 (7–30) |
| Incidence HD patient/year | 44 (24–70) | 46 (28–71) | 48 (31–70) | 46 (28–70) |
aIndigenous—Aboriginal and Torres Strait Islander, Polynesian.
Baseline characteristics of adult patients commencing dialysis in Australia between 2005 and 2022.
| . | Descriptive statistics . | |||
|---|---|---|---|---|
| Characteristics . | Haemodialysis via autologous AVF . | Haemodialysis via CVC . | Peritoneal dialysis . | Overall . |
| Patient-level characteristics | ||||
| Number of patients | 14 298 | 20 620 | 12 494 | 47 412 |
| Age starting dialysis (years, mean ± SD) | 62.7 (14.0) | 60.9 (15.8) | 59.7 (15.2) | 61.1 (15.1) |
| Men (n, %) | 9419 (66) | 12 486 (61) | 7682 (62) | 29 587 (62) |
| Ethnicity (n, %) | ||||
| Caucasians | 10 456 (74) | 14 325 (70) | 8415 (68) | 33 196 (71) |
| Asians | 1090 (8) | 1771 (9) | 2148 (17) | 5009 (11) |
| Indigenousa | 1911 (13) | 3418 (17) | 1066 (9) | 6395 (14) |
| Others | 728 (5) | 942 (5) | 767 (6) | 2437 (5) |
| BMI (mean ± SD) | 29.8 (7.4) | 28.5 (7.8) | 27.3 (5.7) | 28.6 (7.2) |
| BMI categories (n, %) | ||||
| Underweight | 251 (2) | 733 (4) | 342 (3) | 1326 (3) |
| Normal | 3543 (25) | 6507 (32) | 4157 (34) | 14207 (31) |
| Overweight | 4368 (31) | 6093 (30) | 4402 (36) | 14863 (32) |
| Obese | 5895 (42) | 6789 (34) | 3457 (28) | 16141 (35) |
| Dialysis modality (n, %) | ||||
| Peritoneal dialysis | 12 494 (100) | 12 94 (26) | ||
| Haemodialysis | ||||
| Facility haemodialysis | 13 819 (97) | 20 578 (99.8) | 34 397 (73) | |
| Home haemodialysis | 479 (3) | 42 (0.2) | 521 (1) | |
| Smoking status (n, %) | ||||
| Non-smoker | 6690 (48) | 9568 (47) | 6311 (51) | 22 569 (48) |
| Current smoker | 1570 (11) | 2784 (14) | 1323 (11) | 5677 (12) |
| Ex-smoker | 5797 (41) | 7980 (39) | 4728 (38) | 18 505 (40) |
| Comorbidities | ||||
| Chronic lung disease (n, %) | 1705 (12) | 3053 (15) | 1069 (9) | 5827 (12) |
| Coronary artery disease (n, %) | 4637 (33) | 7426 (36) | 3284 (26) | 15 347 (33) |
| Peripheral vascular disease (n, %) | 2310 (16) | 3964 (19) | 1647 (13) | 7921 (17) |
| Cerebrovascular disease (n, %) | 1434 (10) | 2391 (12) | 1099 (9) | 4924 (10) |
| Diabetes mellitus (n, %) | ||||
| Type 1 | 519 (4) | 983 (5) | 711 (6) | 2213 (5) |
| Type 2 | 6817 (48) | 9920 (48) | 4905 (39) | 21 642 (46) |
| Cancer (n, %) | 1743 (12) | 2688 (13) | 1056 (9) | 5487 (12) |
| Late nephrologist referral (n, %) | 799 (6) | 7215 (35) | 1294 (11) | 9308 (20) |
| Cause of kidney failure (n, %) | ||||
| Diabetic nephropathy | 5573 (39) | 8110 (40) | 4280 (34) | 17 963 (38) |
| Glomerular kidney disease | 2584 (18) | 3713 (18) | 2983 (24) | 9280 (20) |
| Hypertension nephrosclerosis | 2048 (14) | 2855 (14) | 1817 (15) | 6720 (14) |
| Familial/genetic kidney disease | 1481 (10) | 687 (3) | 1063 (9) | 3231 (7) |
| Tubulointerstitial disease | 1310 (9) | 1675 (8) | 1121 (9) | 4106 (9) |
| Others | 1214 (9) | 3431 (17) | 1173 (9) | 5818 (12) |
| Geographical location (n, %) | ||||
| Urban | 9371 (66) | 13 421 (66) | 8739 (70) | 31 531 (67) |
| Regional | 3900 (28) | 5411 (27) | 3186 (26) | 12 497 (27) |
| Remote | 909 (6) | 1602 (8) | 499 (4) | 3010 (6) |
| Socio-economic status (n, %) | ||||
| Low | 4258 (30) | 6333 (31) | 3909 (32) | 14 500 (31) |
| Mid | 5444 (38) | 7715 (38) | 4707 (38) | 17 866 (38) |
| High | 4469 (32) | 6379 (31) | 3804 (31) | 14 651 (31) |
| State/territory at dialysis initiation (n, %) | ||||
| New South Wales | 3685 (26) | 6027 (29) | 4591 (37) | 14 303 (30) |
| Queensland | 2933 (21) | 4156 (20) | 2383 (19) | 9472 (20) |
| Victoria | 3770 (26) | 4678 (23) | 2937 (24) | 11 385 (24) |
| Australian Capital Territory | 301 (2) | 518 (3) | 162 (1) | 981 (2) |
| South Australia | 1316 (9) | 1246 (6) | 816 (7) | 3378 (7) |
| Western Australia | 1404 (10) | 2573 (13) | 1216 (10) | 5193 (11) |
| Northern Territory | 605 (4) | 1017 (5) | 159 (1) | 1781 (4) |
| Tasmania | 284 (2) | 405 (2) | 230 (2) | 919 (2) |
| Era (n, %) | ||||
| 2005–10 | 3957 (28) | 6249 (30) | 3318 (27) | 13 524 (29) |
| 2011–16 | 4702 (33) | 6246 (30) | 4244 (34) | 15 192 (32) |
| 2017–22 | 5639 (39) | 8125 (40) | 4932 (40) | 18 696 (39) |
| Pre-emptive transplant (n, %) | 78 (0.5) | 125 (0.6) | 91 (0.7) | 294 (0.6) |
| Centre-level characteristics | ||||
| Number of centres | 101 | 104 | 67 | 106 |
| Transplant centre (n, %) | 17 (17) | 17 (16) | 16 (24) | 18 (17) |
| Centre size (median, IQR) | ||||
| Incidence dialysis patient/year | 57 (31–101) | 62 (38–101) | 78 (45–113) | 64 (38–106) |
| Incidence PD patient/year | 13 (5–27) | 15 (6–27) | 22 (7–39) | 16 (7–30) |
| Incidence HD patient/year | 44 (24–70) | 46 (28–71) | 48 (31–70) | 46 (28–70) |
| . | Descriptive statistics . | |||
|---|---|---|---|---|
| Characteristics . | Haemodialysis via autologous AVF . | Haemodialysis via CVC . | Peritoneal dialysis . | Overall . |
| Patient-level characteristics | ||||
| Number of patients | 14 298 | 20 620 | 12 494 | 47 412 |
| Age starting dialysis (years, mean ± SD) | 62.7 (14.0) | 60.9 (15.8) | 59.7 (15.2) | 61.1 (15.1) |
| Men (n, %) | 9419 (66) | 12 486 (61) | 7682 (62) | 29 587 (62) |
| Ethnicity (n, %) | ||||
| Caucasians | 10 456 (74) | 14 325 (70) | 8415 (68) | 33 196 (71) |
| Asians | 1090 (8) | 1771 (9) | 2148 (17) | 5009 (11) |
| Indigenousa | 1911 (13) | 3418 (17) | 1066 (9) | 6395 (14) |
| Others | 728 (5) | 942 (5) | 767 (6) | 2437 (5) |
| BMI (mean ± SD) | 29.8 (7.4) | 28.5 (7.8) | 27.3 (5.7) | 28.6 (7.2) |
| BMI categories (n, %) | ||||
| Underweight | 251 (2) | 733 (4) | 342 (3) | 1326 (3) |
| Normal | 3543 (25) | 6507 (32) | 4157 (34) | 14207 (31) |
| Overweight | 4368 (31) | 6093 (30) | 4402 (36) | 14863 (32) |
| Obese | 5895 (42) | 6789 (34) | 3457 (28) | 16141 (35) |
| Dialysis modality (n, %) | ||||
| Peritoneal dialysis | 12 494 (100) | 12 94 (26) | ||
| Haemodialysis | ||||
| Facility haemodialysis | 13 819 (97) | 20 578 (99.8) | 34 397 (73) | |
| Home haemodialysis | 479 (3) | 42 (0.2) | 521 (1) | |
| Smoking status (n, %) | ||||
| Non-smoker | 6690 (48) | 9568 (47) | 6311 (51) | 22 569 (48) |
| Current smoker | 1570 (11) | 2784 (14) | 1323 (11) | 5677 (12) |
| Ex-smoker | 5797 (41) | 7980 (39) | 4728 (38) | 18 505 (40) |
| Comorbidities | ||||
| Chronic lung disease (n, %) | 1705 (12) | 3053 (15) | 1069 (9) | 5827 (12) |
| Coronary artery disease (n, %) | 4637 (33) | 7426 (36) | 3284 (26) | 15 347 (33) |
| Peripheral vascular disease (n, %) | 2310 (16) | 3964 (19) | 1647 (13) | 7921 (17) |
| Cerebrovascular disease (n, %) | 1434 (10) | 2391 (12) | 1099 (9) | 4924 (10) |
| Diabetes mellitus (n, %) | ||||
| Type 1 | 519 (4) | 983 (5) | 711 (6) | 2213 (5) |
| Type 2 | 6817 (48) | 9920 (48) | 4905 (39) | 21 642 (46) |
| Cancer (n, %) | 1743 (12) | 2688 (13) | 1056 (9) | 5487 (12) |
| Late nephrologist referral (n, %) | 799 (6) | 7215 (35) | 1294 (11) | 9308 (20) |
| Cause of kidney failure (n, %) | ||||
| Diabetic nephropathy | 5573 (39) | 8110 (40) | 4280 (34) | 17 963 (38) |
| Glomerular kidney disease | 2584 (18) | 3713 (18) | 2983 (24) | 9280 (20) |
| Hypertension nephrosclerosis | 2048 (14) | 2855 (14) | 1817 (15) | 6720 (14) |
| Familial/genetic kidney disease | 1481 (10) | 687 (3) | 1063 (9) | 3231 (7) |
| Tubulointerstitial disease | 1310 (9) | 1675 (8) | 1121 (9) | 4106 (9) |
| Others | 1214 (9) | 3431 (17) | 1173 (9) | 5818 (12) |
| Geographical location (n, %) | ||||
| Urban | 9371 (66) | 13 421 (66) | 8739 (70) | 31 531 (67) |
| Regional | 3900 (28) | 5411 (27) | 3186 (26) | 12 497 (27) |
| Remote | 909 (6) | 1602 (8) | 499 (4) | 3010 (6) |
| Socio-economic status (n, %) | ||||
| Low | 4258 (30) | 6333 (31) | 3909 (32) | 14 500 (31) |
| Mid | 5444 (38) | 7715 (38) | 4707 (38) | 17 866 (38) |
| High | 4469 (32) | 6379 (31) | 3804 (31) | 14 651 (31) |
| State/territory at dialysis initiation (n, %) | ||||
| New South Wales | 3685 (26) | 6027 (29) | 4591 (37) | 14 303 (30) |
| Queensland | 2933 (21) | 4156 (20) | 2383 (19) | 9472 (20) |
| Victoria | 3770 (26) | 4678 (23) | 2937 (24) | 11 385 (24) |
| Australian Capital Territory | 301 (2) | 518 (3) | 162 (1) | 981 (2) |
| South Australia | 1316 (9) | 1246 (6) | 816 (7) | 3378 (7) |
| Western Australia | 1404 (10) | 2573 (13) | 1216 (10) | 5193 (11) |
| Northern Territory | 605 (4) | 1017 (5) | 159 (1) | 1781 (4) |
| Tasmania | 284 (2) | 405 (2) | 230 (2) | 919 (2) |
| Era (n, %) | ||||
| 2005–10 | 3957 (28) | 6249 (30) | 3318 (27) | 13 524 (29) |
| 2011–16 | 4702 (33) | 6246 (30) | 4244 (34) | 15 192 (32) |
| 2017–22 | 5639 (39) | 8125 (40) | 4932 (40) | 18 696 (39) |
| Pre-emptive transplant (n, %) | 78 (0.5) | 125 (0.6) | 91 (0.7) | 294 (0.6) |
| Centre-level characteristics | ||||
| Number of centres | 101 | 104 | 67 | 106 |
| Transplant centre (n, %) | 17 (17) | 17 (16) | 16 (24) | 18 (17) |
| Centre size (median, IQR) | ||||
| Incidence dialysis patient/year | 57 (31–101) | 62 (38–101) | 78 (45–113) | 64 (38–106) |
| Incidence PD patient/year | 13 (5–27) | 15 (6–27) | 22 (7–39) | 16 (7–30) |
| Incidence HD patient/year | 44 (24–70) | 46 (28–71) | 48 (31–70) | 46 (28–70) |
aIndigenous—Aboriginal and Torres Strait Islander, Polynesian.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
